Detalles de la búsqueda
1.
Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung Cancer.
Am J Clin Oncol
; 47(2): 49-55, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011024
2.
Race, Ethnicity, and Socioeconomic Factors as Determinants of Cachexia Incidence and Outcomes in a Retrospective Cohort of Patients With Gastrointestinal Tract Cancer.
JCO Oncol Pract
; 19(7): 493-500, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099735
3.
Racial, Ethnic, and Socioeconomic Characteristics Independently Predict for Cachexia Risk and Associated Survival Outcomes in Stage IV NSCLC: A Brief Report.
JTO Clin Res Rep
; 4(4): 100496, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37095748
4.
Associations of Prior Chronic Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Glucocorticoids With Cachexia Incidence and Survival.
Front Oncol
; 12: 922418, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35747801
5.
Primary Tumor Fluorine-18 Fluorodeoxydglucose (18F-FDG) Is Associated With Cancer-Associated Weight Loss in Non-Small Cell Lung Cancer (NSCLC) and Portends Worse Survival.
Front Oncol
; 12: 900712, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35814438
6.
A preponderance of gastrointestinal cancer patients transition into cachexia syndrome.
J Cachexia Sarcopenia Muscle
; 13(6): 2920-2931, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36165100
7.
The influence of tumour fluorodeoxyglucose avidity and cachexia development on patient survival in oesophageal or gastroesophageal junction cancer.
JCSM Clin Rep
; 6(4): 128-136, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35721304
Resultados
1 -
7
de 7
1
Próxima >
>>